Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Иммунологическая память к SARS-CoV-2 оценивалась в течение до 8 месяцев после инфекции
2021-01-06
SCID: 54.1/peq86mnf
Discuss with AI
SARS-CoV-2 immune memorySARS-CoV-2-specific CD4+ T cellsSARS-CoV-2-specific CD8+ T cellsSpike-specific IgGSpike-specific memory B cells
Figures from the paper
Abstract (AI)
ABSTRACT Understanding immune memory to SARS-CoV-2 is critical for improving diagnostics and vaccines, and for assessing the likely future course of the COVID-19 pandemic. We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at ≥ 6 months post-infection. IgG to the Spike protein was relatively stable over 6+ months. Spike-specific memory B cells were more abundant at 6 months than at 1 month post symptom onset. SARS-CoV-2-specific CD4 + T cells and CD8 + T cells declined with a half-life of 3-5 months. By studying antibody, memory B cell, CD4 + T cell, and CD8 + T cell memory to SARS-CoV-2 in an integrated manner, we observed that each component of SARS-CoV-2 immune memory exhibited distinct kinetics.
Key Findings
1
Different components of SARS-CoV-2 immune memory (antibodies, memory B cells, CD4+ T cells, CD8+ T cells) show distinct kinetic profiles when assessed together.
2
IgG antibodies to the SARS-CoV-2 spike protein remained relatively stable for at least 6+ months after infection.
3
SARS-CoV-2-specific CD4+ and CD8+ T cells declined over time with estimated half-lives of approximately 3 to 5 months.
4
Spike-specific memory B cells increased in abundance by 6 months compared to 1 month after symptom onset.
5
The study analyzed multiple immune memory compartments in 254 samples from 188 COVID-19 cases, including 43 samples at ≥6 months post-infection.
Research Object
Circulating immune memory to SARS-CoV-2 in recovered COVID-19 cases
Research Subject
Kinetics and durability of multiple immune-memory compartments (spike-specific IgG, memory B cells, CD4+ T cells, CD8+ T cells) up to eight months after infection
Publication Details
Publication Date
2021-01-06
Journal
Publisher
ISSN
Cited by
2670
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest